Top Markets
#1 Black Phoenix Black Phoenix +335.94%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +66.31%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.65%
#6 OpenEden OpenEden +34.31%
#7 BasedHype BasedHype +27.14%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.88%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +18.65%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Lotus Pharmaceuticals, Inc. Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUS
Rang in aandelen #40779
Lotus Pharmaceuticals, Inc. currently has no substantial business activities.... Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Aandeelprijs
$0.003
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$82.31K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-62.64%
Land
US
Handel Lotus Pharmaceuticals, Inc. (LTUS)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Lotus Pharmaceuticals, Inc. (LTUS)
Het dividendrendement (TTM) van Lotus Pharmaceuticals, Inc. (aandelsymbool: LTUS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Lotus Pharmaceuticals, Inc. (LTUS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.56%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US